# Kiniksa Pharmaceuticals International, plc (KNSA) - Q2 2025 earnings

Reported July 29, 2025.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $156.8M | $166.5M |
| EPS | $0.23 | $0.18 |

Earnings filing reader: [8-K 0001104659-25-071413](https://www.opencapital.sh/filings/0001104659-25-071413)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001104659-25-071413.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1730430/0001104659-25-071413-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1730430/0001558370-25-009738-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/knsa/earnings/q2-2025